Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adefovir

Drug Profile

Adefovir

Alternative Names: GS 0393; GS 393; Phosphonylmethoxyethyl-a; PMEA

Latest Information Update: 21 Aug 2007

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Academy of Sciences of the Czech Republic; Nonindustrial source; Rega Institute for Medical Research
  • Developer Academy of Sciences of the Czech Republic; Gilead Sciences; Nonindustrial source
  • Class Adenine nucleotides; Antiretrovirals; Phosphonic acids; Purine nucleotides; Small molecules
  • Mechanism of Action Cell differentiation stimulants; DNA-directed DNA polymerase inhibitors; Immunomodulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Graft-versus-host disease; Hepatitis B; HIV infections; Rheumatic disorders

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 08 May 2000 Discontinued-II for HIV infections treatment in USA (IV)
  • 08 May 2000 Discontinued-Preclinical for Hepatitis B in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top